Goodwill of Sunshine Biopharma Inc. from 31 Dec 2017 to 31 Dec 2024

Taxonomy & unit
us-gaap: USD
Description
Amount after accumulated impairment loss of an asset representing future economic benefits arising from other assets acquired in a business combination that are not individually identified and separately recognized.
Summary
Sunshine Biopharma Inc. quarterly Goodwill in USD history and change rate from 31 Dec 2017 to 31 Dec 2024.
  • Sunshine Biopharma Inc. Goodwill for the quarter ending 31 Dec 2024 was $0.
Source SEC data
View on sec.gov
Goodwill, Quarterly (USD)
Goodwill, YoY Quarterly Change (%)

Sunshine Biopharma Inc. Quarterly Goodwill (USD)

Period Value YoY Chg Change % Date Report Filed Fiscal Year Fiscal Period
Q4 2024 $0 $0 31 Dec 2024 10-K 01 Apr 2025 2024 FY
Q4 2023 $0 $0 31 Dec 2023 10-K 01 Apr 2025 2024 FY
Q4 2022 $0 $0 31 Dec 2022 10-K 01 Apr 2025 2024 FY
Q4 2021 $0 31 Dec 2021 10-K 01 Apr 2025 2024 FY
Q4 2019 $665,697 $0 0% 31 Dec 2019 10-K 30 Mar 2021 2020 FY
Q1 2019 $665,697 -$7,949 -1.2% 31 Mar 2019 10-Q 20 May 2019 2019 Q1
Q4 2018 $665,697 +$665,697 31 Dec 2018 10-K 01 May 2020 2019 FY
Q3 2018 $673,646 30 Sep 2018 10-Q 16 Nov 2018 2018 Q3
Q2 2018 $673,646 30 Jun 2018 10-Q 17 Aug 2018 2018 Q2
Q1 2018 $673,646 31 Mar 2018 10-Q 22 May 2018 2018 Q1
Q4 2017 $0 31 Dec 2017 10-K 12 Apr 2019 2018 FY
* An asterisk sign (*) next to the value indicates that the value is likely invalid.